Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Damodar Valley Corporation
KODERMA, JHARKHAND
Bid Publish Date
27-Oct-2024, 10:55 am
Bid End Date
18-Nov-2024, 11:00 am
Progress
Quantity
206747
Category
Title1
Bid Type
Two Packet Bid
Dg Armed Forces Medical Service has released a public tender for Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18, Title19, Title20, Title21, Title22, Title23, Title24, Title25, Title26, Title27, Title28, Title29, Title30, Title31, Title32, Title33, Title34, Title35, Title36, Title37, Title38, Title39, Title40, Title41, Title42, Title43, Title44, Title45, Title46, Title47, Title48, Title49, Title50, Title51, Title52, Title53, Title54, Title55, Title56, Title57, Title58, Title59, Title60, Title61, Title62, Title63, Title64, Title65, Title66, Title67, Title68, Title69, Title70, Title71, Title72, Title73, Title74, Title75, Title76, Title77, Title78, Title79, Title80, Title81, Title82. Quantity: 206747. Submission Deadline: 18-11-2024 11: 00: 00. Download documents and apply online.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Damodar Valley Corporation
KODERMA, JHARKHAND
National Security Guard (nsg)
GUNTUR, ANDHRA PRADESH
Joint Venture Of Cil, Ntpc, Iocl, Fcil & Hfcl
GORAKHPUR, UTTAR PRADESH
Indian Army
JABALPUR, MADHYA PRADESH
Indian Army
JABALPUR, MADHYA PRADESH
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Lignocaine HCl 2 percent with Adrenaline 30 ml Inj | 30 | vial | buyer@328 | 21 |
| 2 | Title2 | Inj Pentazocine Lactate 30 mg Per 1 ml Amp | 240 | amp | buyer@328 | 21 |
| 3 | Title3 | Paracetamol with Cysteine HCl monohydrate infusion 1000 mg per 100 ml | 330 | bott | buyer@328 | 21 |
| 4 | Title4 | Diclofenac 25 mg per ml IP 3 ml Inj | 2,100 | amp | buyer@328 | 21 |
| 5 | Title5 | Naproxen 250 mg Tab | 3,000 | no | buyer@328 | 21 |
| 6 | Title6 | Paracetamol 500 mg Tab | 22,500 | no | buyer@328 | 21 |
| 7 | Title7 | Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone Phosphate 4 mg per ml 2 ml Inj | 450 | vial | buyer@328 | 21 |
| 8 | Title8 | Hydrocortisone Sodium Succininate 100 mg Inj | 900 | vial | buyer@328 | 21 |
| 9 | Title9 | Noradrenaline Bitartrate 2 mg per ml 2 ml Inj | 45 | amp | buyer@328 | 21 |
| 10 | Title10 | Prednisolone 5 mg Tab | 3,600 | no | buyer@328 | 21 |
| 11 | Title11 | Pregabalin 75 mg Cap Tab | 4,200 | no | buyer@328 | 21 |
| 12 | Title12 | Phenytoin Sodium 100 mg Tab | 600 | no | buyer@328 | 21 |
| 13 | Title13 | Sodium Valproate 200 mg Tab | 600 | no | buyer@328 | 21 |
| 14 | Title14 | Clotrimazole mouth paint 1 percent bottle of 15 ml | 360 | bott | buyer@328 | 21 |
| 15 | Title15 | Itraconazole 100 mg Cap | 6,900 | no | buyer@328 | 21 |
| 16 | Title16 | Silver Sulphadiazine 1 percent Ointment 20 gm tube | 450 | tube | buyer@328 | 21 |
| 17 | Title17 | Ondansetron 2mg ml 4 ml Inj | 1,050 | amp | buyer@328 | 21 |
| 18 | Title18 | Choline Salicylate and Benzalkonium chloride gel of 10 ml | 360 | tube | buyer@328 | 21 |
| 19 | Title19 | Adenosine 3 mg per ml 2 ml Inj | 60 | amp | buyer@328 | 21 |
| 20 | Title20 | Ecosporin 75mg and Atorvastatin 20mg | 1,200 | no | buyer@328 | 21 |
| 21 | Title21 | Amiodarone HCl 150 mg 3 ml Inj | 45 | amp | buyer@328 | 21 |
| 22 | Title22 | Atorvastatin 10 mg Tab | 4,500 | no | buyer@328 | 21 |
| 23 | Title23 | Nifedipine 20mg | 5,100 | no | buyer@328 | 21 |
| 24 | Title24 | Ramipiril 2 5 mg Tab | 3,000 | no | buyer@328 | 21 |
| 25 | Title25 | Tab Metoprolol XL 25 mg | 1,050 | no | buyer@328 | 21 |
| 26 | Title26 | Clopidogrel 75 mg Tab | 7,200 | no | buyer@328 | 21 |
| 27 | Title27 | Amlodipine Besylate 5 mg Tab | 6,000 | no | buyer@328 | 21 |
| 28 | Title28 | Hydrochlorothiazide 25mg | 2,400 | no | buyer@328 | 21 |
| 29 | Title29 | Telmisartan 40 mg and Hydrochlorothiazide 12 point 5 mg Tab | 3,000 | no | buyer@328 | 21 |
| 30 | Title30 | Desensitising paste Stannous Fluoride Potassium Nitrate Sodium monofluro phosphate Tube of 40 to 55 ml or gm | 450 | tube | buyer@328 | 21 |
| 31 | Title31 | Adapalene 0 point 1 percentTube of 15 gm | 75 | tube | buyer@328 | 21 |
| 32 | Title32 | Mometasone 0 point 1 percent tube of 10 gm | 600 | tube | buyer@328 | 21 |
| 33 | Title33 | Mupirocin 2 percent Oint tube of 5 gm | 840 | tube | buyer@328 | 21 |
| 34 | Title34 | Povidone Iodine Oint 10 percent or 5 percent 20gm 15gm tube | 720 | tube | buyer@328 | 21 |
| 35 | Title35 | Para dichlorobenzene 2 percent w v Benzocaine 2 point 7 percent wv Chlorbutol 5 percent Turpentine oil 15 percent wv bott of 10 ml | 225 | bott | buyer@328 | 21 |
| 36 | Title36 | Povidone Iodine Germicidal Gargle 2 percent w v | 135 | bott | buyer@328 | 21 |
| 37 | Title37 | Hydrogen peroxide solution with stabilizer IP 20 volume 500 ml bott | 90 | bott | buyer@328 | 21 |
| 38 | Title38 | Frusemide 20 mg 2 ml Inj | 300 | amp | buyer@328 | 21 |
| 39 | Title39 | Trypsin with chymotrypsin Tab | 6,000 | no | buyer@328 | 21 |
| 40 | Title40 | Pantoprazole 40mg Tab | 28,500 | no | buyer@328 | 21 |
| 41 | Title41 | Ranitidine HCl 50 mg 2 ml Inj | 690 | amp | buyer@328 | 21 |
| 42 | Title42 | Domperidone 10 mg Tab | 5,400 | no | buyer@328 | 21 |
| 43 | Title43 | Anti haemorhoidal Ointment containing Betamethasone 005 percent Phenylephrine 0 point 1 Lignocaine 2 point 5 percent tube of 15 gm with applicator | 450 | tube | buyer@328 | 21 |
| 44 | Title44 | Dicyclomine HCl 20mg Inj | 450 | amp | buyer@328 | 21 |
| 45 | Title45 | Enema Sodium phosphate 6 percent Sodium Acid phosphate 16 percent pack of 100 ml | 20 | pack | buyer@328 | 21 |
| 46 | Title46 | Loperamide 2mg Tab | 600 | no | buyer@328 | 21 |
| 47 | Title47 | Tab Thyroxine 50 mcg | 600 | no | buyer@328 | 21 |
| 48 | Title48 | Magnesium sulphate 50 percent w v Inj | 6 | amp | buyer@328 | 21 |
| 49 | Title49 | Alfacalcidol Vit D3 0 point 25mcg Cap | 1,800 | no | buyer@328 | 21 |
| 50 | Title50 | Flurbiprofen Sodium ophthalmic soln 0 point 03 percent vial of 5 ml | 450 | vial | buyer@328 | 21 |
| 51 | Title51 | Moxifloxacin 0 point 5 percent preservative free Eye drops | 105 | bott | buyer@328 | 21 |
| 52 | Title52 | Ofloxacin 0 point 3 percent bott of 5 ml | 105 | bott | buyer@328 | 21 |
| 53 | Title53 | Timolol Maleate eye drops 0 point 5 percent bott of 5 ml | 24 | bott | buyer@328 | 21 |
| 54 | Title54 | Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml | 210 | no | buyer@328 | 21 |
| 55 | Title55 | Sodium Chloride 0 point 65 percent w v Nasal drops of 15 ml | 540 | bott | buyer@328 | 21 |
| 56 | Title56 | Cinnarizine 25 mg Tab | 900 | no | buyer@328 | 21 |
| 57 | Title57 | Haloperidol 5mg ml Inj | 12 | amp | buyer@328 | 21 |
| 58 | Title58 | Ipratropium Bromide Respirator soln 500 mcg 2 ml respule | 450 | no | buyer@328 | 21 |
| 59 | Title59 | Cough Expectorant Syrup Each 5 ml containing Diphenhydramine Hydrochloride 14 mg Ammonium Chloride 0 point 135 g Sodium Citrate 57 mg Menthol 0 point 9 mg Bott of 110 ml | 1,200 | bott | buyer@328 | 21 |
| 60 | Title60 | Syrup Terbutaline sulphate 1 point 25 mg and Bromhexine HCl 4 mg and Guaiphenesin 50 mg per 5 ml bottle of 100 ml | 540 | no | buyer@328 | 21 |
| 61 | Title61 | Dextrose 50 percent 25 ml Inj | 240 | amp | buyer@328 | 21 |
| 62 | Title62 | Linezolid 600 mg Tab | 600 | no | buyer@328 | 21 |
| 63 | Title63 | Anti phlebitis cream Tube of 15 g 20 g | 240 | tube | buyer@328 | 21 |
| 64 | Title64 | Potassium Citrate 1100mg Citric Acid or Magnesium Citrate 300 to 400mg per 5ml bott of 200ml | 360 | bott | buyer@328 | 21 |
| 65 | Title65 | Tamsulosin HCl 0 point 4 mg Cap | 300 | no | buyer@328 | 21 |
| 66 | Title66 | Ascorbic Acid 500 mg Tab | 4,500 | no | buyer@328 | 21 |
| 67 | Title67 | Vit B 12 500 mcg ml Inj | 105 | amp | buyer@328 | 21 |
| 68 | Title68 | Calcium Carbonate 500mg Tab elemental and Vit D3 to200 IU to 250 IU Tab | 15,000 | no | buyer@328 | 21 |
| 69 | Title69 | Calcium 9 mg and Calcium gluconate 50 mg Inj for IV use 10 ml Injection | 105 | amp | buyer@328 | 21 |
| 70 | Title70 | Multivitamin drops with constitutents having Vit A Vit B1 B2 B6 Vit C Vit D bottle of 15 mlosages as per recommended daily allowances | 90 | bott | buyer@328 | 21 |
| 71 | Title71 | Levo-Salbutamol 1 point25 mg and Ipratropium 500 mcg in 2 point 5 ml Respule | 900 | no | buyer@328 | 21 |
| 72 | Title72 | Fexofenadine Hydrochloride Tab 120 mg | 5,400 | no | buyer@328 | 21 |
| 73 | Title73 | Amoxycillin 500 mg and Clavulanic Acid 125 mg Tab | 12,000 | no | buyer@328 | 21 |
| 74 | Title74 | Cefotaxime Sodium 1gm Inj | 540 | vial | buyer@328 | 21 |
| 75 | Title75 | Cefuroxime 250 mg Tab | 1,500 | no | buyer@328 | 21 |
| 76 | Title76 | Doxycycline Cap 100mg | 3,000 | no | buyer@328 | 21 |
| 77 | Title77 | Cefixime 200 mg Tab | 4,500 | no | buyer@328 | 21 |
| 78 | Title78 | Antacid chewable containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab | 21,000 | no | buyer@328 | 21 |
| 79 | Title79 | Inj Thiamine 100 mg ml 2 ml Amp | 60 | amp | buyer@328 | 21 |
| 80 | Title80 | Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses | 750 | vial | buyer@328 | 21 |
| 81 | Title81 | Anti chillblain cream Tube of 20 gm | 900 | tube | buyer@328 | 21 |
| 82 | Title82 | Cold Injury protection Skin cream aloevera 50 percent Vol 200ml ALOCAL Cont Aloevera 50percent Vit E 0 point 2percent Sesame Oil 2percent Methyl Paraben 0 point 1percent Sodium Benzoate 0point 1percent Brand ALOCAL SKIN CREAM DRDO Approved only | 900 | no | buyer@328 | 21 |
Discover companies most likely to bid on this tender
The eligibility requirements for participation include being a registered entity in the pharmaceutical industry, possessing a valid GST registration, and holding necessary licenses for the manufacture and distribution of medicinal products. Additionally, bidders must demonstrate experience in fulfilling similar contracts.
Bidders must provide a range of certificates including a valid GST registration, manufacturing licenses, and any additional certifications relevant to the specific medicines listed in the tender. All documentation should be up-to-date and compliant with industry standards.
To participate in the tender, interested bidders must register on the GeM portal, following the registration process outlined on the website. This process involves creating a company profile, submitting required documents, and ensuring compliance with all registration protocols.
Accepted document formats for tender submission include PDFs and other digital files that comply with the specifications provided in the tender documents. Uploading all files in the required formats ensures smooth processing of bids.
The technical specifications include details such as the formulation, dosage, packaging, and shelf life of each medicinal product. Bidders must adhere to these specifications to ensure the quality and efficacy of the products supplied.
Yes, all products must adhere to national pharmaceutical quality standards, which include compliance with testing and inspection protocols as set out by regulatory authorities. Bidders must ensure that all medicines meet these standards prior to delivery.
Bidders must comply with all applicable compliance requirements, which include adherence to pharmaceutical regulations, timely submission of documents, and adherence to the terms and conditions specified in the tender document.
Yes, specific testing criteria will be outlined within the tender documentation, which may include stability testing, potency analysis, and other assessments as necessary to ensure product quality upon delivery.
The Earnest Money Deposit (EMD) is typically required to secure the bid and demonstrate the intent to fulfill contractual obligations. Details regarding the specific amount and submission process will be outlined in the tender documents.
Bidders may be required to provide performance security as part of the contract, which acts as a guarantee for the fulfillment of the terms laid out in the agreement. This may involve a percentage of the total contract value.
The payment terms will be specified in the tender document and typically involve structured payments based on delivery milestones or may include upfront payments against performance bonds. Bid submissions should reflect these terms in financial proposals.
The price evaluation will consider the total bid amount, focusing on competitive pricing, and the lowest-priced bid that meets technical requirements will generally be favored during the evaluation process.
Bids must be submitted electronically through the GeM portal according to the instructions provided in the tender documentation. Ensure all required documents are uploaded before the submission deadline.
The tender documents outline critical timelines for submission and evaluation, including submission deadlines and potential dates for bid opening. Bidders should adhere to these timelines rigorously.
Notification of results will be communicated through the GeM platform, and successful bidders will receive further instructions regarding the next steps in procurement.
MSEs are afforded certain benefits under government procurement policies, which may include price relaxation, priority in evaluation, and support in the bidding process.
Yes, startups may receive special considerations in the evaluation process, including relaxations in eligibility criteria and support in navigating the procurement guidelines.
This tender supports the 'Make in India' initiative by promoting local manufacturing and procurement of essential medicines, thereby contributing to self-reliance in the healthcare sector.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS